<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="discussion" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="epub">1935-2735</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PNTD-VP-0651R4</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0000765</article-id><article-categories><subj-group subj-group-type="heading"><subject>Viewpoints</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Evidence-Based Healthcare/Methods for Diagnostic and Therapeutic Studies</subject><subject>Infectious Diseases/Neglected Tropical Diseases</subject><subject>Infectious Diseases/Viral Infections</subject><subject>Virology/Diagnosis</subject></subj-group></article-categories><title-group><article-title>More Accurate Insight into the Incidence of Human Rabies in Developing Countries through Validated Laboratory Techniques</article-title><alt-title alt-title-type="running-head">Human Rabies Diagnosis in Developing Countries</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dacheux</surname><given-names>Laurent</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wacharapluesadee</surname><given-names>Supaporn</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hemachudha</surname><given-names>Thiravat</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Meslin</surname><given-names>François-Xavier</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Buchy</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Reynes</surname><given-names>Jean-Marc</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bourhy</surname><given-names>Hervé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Institut Pasteur, Dynamics and Host Adaptation Unit, National Reference Centre for Rabies, WHO Collaborative Centre for Reference and Research on Rabies, Paris, France</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Molecular Biology Laboratory for Neurological Diseases, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Neglected Zoonotic Diseases, Department of Neglected Tropical Diseases, Cluster HIV/AIDS, Malaria, Tuberculosis and Neglected Tropical Diseases (HTM), WHO Headquarters, Geneva, Switzerland</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Institut Pasteur du Cambodge, Virology Unit, Cambodia</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Centre Pasteur du Cameroun, Virology Unit, Cameroon</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Lustigman</surname><given-names>Sara</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">New York Blood Center, United States of America</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">laurent.dacheux@pasteur.fr</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>11</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2010</year></pub-date><volume>4</volume><issue>11</issue><elocation-id>e765</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Dacheux et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><funding-group><funding-statement>Major funding for the project in Institut Pasteur was provided by the Institut Pasteur International Network with Actions Concertees InterPasteuriennes 2003/687 and 2006/562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="5"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>How to Improve Human Rabies Diagnosis in Developing Countries</title>
<p>Over the past 10 years, new techniques and protocols have been proposed for rabies diagnosis, especially in humans. However, the reported number of laboratory-confirmed human rabies cases remains limited and underestimates the real impact of this neglected zoonotic disease, particularly in enzo-epizootic areas of Asia and Africa <xref ref-type="bibr" rid="pntd.0000765-Knobel1">[1]</xref>. The regular reporting of diagnostic data through the structures of the World Organization for Animal Health and the World Health Organization (WHO) (using the RABNET network, for example), together with the importance of the status of rabies as a notifiable disease in all countries, remain crucial for the surveillance and control of rabies, especially in humans. There is clearly a need to improve diagnostic tools appropriate for the facilities in these countries. This paper provides a review of recent publications relating to the evaluation of methods for human rabies diagnosis in developing country settings in order to highlight the sampling methods and techniques that are likely to give the most reliable results.</p>
<p>In their recent review entitled “Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century”, Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref> provide information on some of the latest techniques to detect rabies virus or nucleic acid in diagnostic samples. However, additional major techniques not mentioned by Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref> are also available, some concerning recent studies addressing the broader challenge of human rabies diagnosis in developing countries, which we aim to describe here.</p>
</sec><sec id="s2">
<title>A Key Step: Selection of Biological Samples</title>
<p>Several biological samples can be used for intra-vitam diagnosis of human rabies: saliva, cerebral spinal fluid (CSF), <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref> but also skin biopsies containing hair follicles collected at the nape of the neck, extracted hair follicles, tears, and urine <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>–<xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref>. The collection of brain biopsy samples <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref> should be discouraged for intra-vitam diagnosis and should be restricted to post-mortem diagnosis. Skin biopsies can also be used for the post-mortem diagnosis of rabies encephalitis to replace brain biopsy when the latter is not feasible (which is the case in most of enzootic areas in Asia and Africa where cerebral brain biopsies are rarely authorized by the patient's family) <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Macedo1">[7]</xref>. Because the viral shedding in saliva, CSF, and urine is suggested to be intermittent, multiple different samples (e.g., skin, saliva, urine) must be collected and analyzed by molecular methods for an intra-vitam rabies diagnosis. However, the sensitivity of testing only one skin biopsy per patient has been shown to be ≥98% <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, and it is possible to achieve maximal sensitivity (up to 100%) for furious rabies encephalitis by collecting and testing three serial daily saliva samples per patient <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>. Viral RNA detection from paralytic rabies patients is also possible, although the sensitivity may be lower. In a recent study conducted in Thailand, the sensitivity of detection of paralytic and furious rabies was 50% (<italic>n</italic> = 6) and 92% (<italic>n</italic> = 50) per patient, respectively <xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref>. A summary of the sensitivity results obtained for different biological samples using molecular methods is shown in <xref ref-type="table" rid="pntd-0000765-t001">Table 1</xref>. Two sets of recommendations for sample collection in current use in reference laboratories in both developed and developing countries are shown in <xref ref-type="table" rid="pntd-0000765-t002">Tables 2</xref> and <xref ref-type="table" rid="pntd-0000765-t003">3</xref>.</p>
<table-wrap id="pntd-0000765-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000765.t001</object-id><label>Table 1</label><caption>
<title>Description of Biological Samples Analyzed for Molecular Diagnosis of Human Rabies in Large Cohorts of Suspected or Confirmed Rabid Patients in Local Laboratory Conditions.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pntd-0000765-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000765.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Samples</td>
<td align="left" colspan="1" rowspan="1">Technique (Target Gene)</td>
<td align="left" colspan="1" rowspan="1">Reference</td>
<td align="left" colspan="1" rowspan="1">Country Where the Study Was Performed</td>
<td align="left" colspan="1" rowspan="1">Sensitivity (Number of Samples tested)</td>
<td align="left" colspan="1" rowspan="1">Commentary</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Saliva</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR(L gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
<td align="left" colspan="1" rowspan="1">France, Madagascar, Cambodia</td>
<td align="left" colspan="1" rowspan="1">70.2% (<italic>n</italic> = 84)</td>
<td align="left" colspan="1" rowspan="1">A sensitivity of 100% was observed for three serial daily saliva samples per patient with encephalitic rabies.Liquid saliva (a volume of 200 µL for analysis) is preferable to saliva swab.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">RT-PCR(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Crepin1">[16]</xref></td>
<td align="left" colspan="1" rowspan="1">France</td>
<td align="left" colspan="1" rowspan="1">30% (<italic>n</italic> = 37)</td>
<td align="left" colspan="1" rowspan="1">A volume of 200 µL was used for analysis. A proteinase K lysis step was included.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">NASBA(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref></td>
<td align="left" colspan="1" rowspan="1">Thailand</td>
<td align="left" colspan="1" rowspan="1">75.8% (<italic>n</italic> = 62)</td>
<td align="left" colspan="1" rowspan="1">A volume of 200 µL was used for analysis.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">RT-nPCR(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Nagaraj1">[17]</xref></td>
<td align="left" colspan="1" rowspan="1">India</td>
<td align="left" colspan="1" rowspan="1">37.5% (<italic>n</italic> = 24)</td>
<td align="left" colspan="1" rowspan="1">Pool of three saliva samples collected at intervals of 4–5 h.Confirmation of rabies with reference technique (FAT) is not mentioned in this study.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">RT-qPCR (SYBR Green)(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Nagaraj1">[17]</xref></td>
<td align="left" colspan="1" rowspan="1">India</td>
<td align="left" colspan="1" rowspan="1">75% (<italic>n</italic> = 24)</td>
<td align="left" colspan="1" rowspan="1">Pool of three saliva samples collected at intervals of 4–5 h.Confirmation of rabies with reference technique (FAT) is not mentioned in this study.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skin biopsy</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR(L gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
<td align="left" colspan="1" rowspan="1">France, Madagascar, Cambodia</td>
<td align="left" colspan="1" rowspan="1">98.3% (<italic>n</italic> = 60)</td>
<td align="left" colspan="1" rowspan="1">Collected at the nape of the neck, containing hair follicles.A sensitivity of 100% (<italic>n</italic> = 33) was obtained at hospital admission and 97.2% (<italic>n</italic> = 36) at hospital discharge or death.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">RT-PCR(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Macedo1">[7]</xref></td>
<td align="left" colspan="1" rowspan="1">Brazil</td>
<td align="left" colspan="1" rowspan="1">70% (<italic>n</italic> = 10)</td>
<td align="left" colspan="1" rowspan="1">Most neck-skin biospy samples were collected post-mortem (8/10).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Extracted hair</td>
<td align="left" colspan="1" rowspan="1">NASBA(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref></td>
<td align="left" colspan="1" rowspan="1">Thailand</td>
<td align="left" colspan="1" rowspan="1">50% (<italic>n</italic> = 26)</td>
<td align="left" colspan="1" rowspan="1">At least 20 hairs have to be collected.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Urine</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR(L gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
<td align="left" colspan="1" rowspan="1">France, Madagascar, Cambodia</td>
<td align="left" colspan="1" rowspan="1">9.5% (<italic>n</italic> = 63)</td>
<td align="left" colspan="1" rowspan="1">The difference in sensitivity found in these studies seems to be due to difference of volume of tested samples.At least 1 mL has to be collected and analyzed (as amount of viral RNA found in this samples is low).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">NASBA(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref></td>
<td align="left" colspan="1" rowspan="1">Thailand</td>
<td align="left" colspan="1" rowspan="1">39% (<italic>n</italic> = 41)</td>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CSF</td>
<td align="left" colspan="1" rowspan="1">RT-PCR(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Crepin1">[16]</xref></td>
<td align="left" colspan="1" rowspan="1">France</td>
<td align="left" colspan="1" rowspan="1">8% (<italic>n</italic> = 12)</td>
<td align="left" colspan="1" rowspan="1">A volume of 200 µL was used for analysis. A proteinase K lysis step was included.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">NASBA(N gene)</td>
<td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref></td>
<td align="left" colspan="1" rowspan="1">Thailand</td>
<td align="left" colspan="1" rowspan="1">43.3% (<italic>n</italic> = 30)</td>
<td align="left" colspan="1" rowspan="1">A volume of 200 µL was used for analysis.</td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>FAT, fluorescent antibody test; hnPCR, hemi-nested PCR; L, polymerase; N, nucleoprotein; NASBA, nucleic acid sequence-based amplification; nPCR, nested-PCR; PCR, polymerase chain reaction; qPCR, real-time PCR; RT, reverse transcription.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd-0000765-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000765.t002</object-id><label>Table 2</label><caption>
<title>National Recommendations from the NRC Rabies, WHO-CC for Reference and Research on Rabies, France, Concerning Biological Samples Collected for Diagnosis of Human Rabies.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pntd-0000765-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000765.t002" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="6" rowspan="1">Intra-Vitam Diagnosis of Human Rabies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Samples</td>
<td align="left" colspan="2" rowspan="1">Sensitivity Considering the Clinical Evolution of the Patient (in Days following the Onset of Symptoms)</td>
<td align="left" colspan="1" rowspan="1">Comments<xref ref-type="table-fn" rid="nt102">a</xref></td>
<td align="left" colspan="1" rowspan="1">Storage</td>
<td align="left" colspan="1" rowspan="1">Technique (Reference)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">0–8 Days</td>
<td align="left" colspan="1" rowspan="1">&gt;8 Days</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Saliva (1 mL or saliva swabs)</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">At least three saliva samples collected at intervals of 3–6 hours.Liquid saliva is preferable to saliva swabs.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Urine (at least 1 mL)</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">At least three urine samples collected in an interval of 3–6 hours.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skin biopsy (diameter of 4 mm, total volume of 20 mm<sup>3</sup>)</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">Skin biopsy collected at the nape of the neck, with hair follicles, using biopsy punch (Stiefel).</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Serum (500 µL)</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Sample collection can be repeated, depending on the length of survival period (1–2 samples per week).</td>
<td align="left" colspan="1" rowspan="1">+4°C/−20°C</td>
<td align="left" colspan="1" rowspan="1">RFFIT <xref ref-type="bibr" rid="pntd.0000765-Smith1">[31]</xref> and/or ELISA <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Feyssaguet1">[33]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CSF (&gt;300 µL)</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Sample collection can be repeated, depending on the length of survival period (1–2 samples per week).</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>; RFFIT <xref ref-type="bibr" rid="pntd.0000765-Smith1">[31]</xref> and/or ELISA <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Feyssaguet1">[33]</xref></td>
</tr>
</tbody>
</table><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="5" rowspan="1">Post-Mortem Diagnosis of Human Rabies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Samples</td>
<td align="left" colspan="1" rowspan="1">Sensitivity</td>
<td align="left" colspan="1" rowspan="1">Comments</td>
<td align="left" colspan="1" rowspan="1">Storage</td>
<td align="left" colspan="1" rowspan="1">Technique (Reference)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Brain biopsy</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">Brain biopsy collected via the orbital route with Tru-Cut biopsy needles for soft tissues with manual clip (Allegiance) or via the occipital route using lumbar puncture needles.</td>
<td align="left" colspan="1" rowspan="1">+4°C/−20°C</td>
<td align="left" colspan="1" rowspan="1">FAT <xref ref-type="bibr" rid="pntd.0000765-Dean1">[28]</xref>; RTCIT <xref ref-type="bibr" rid="pntd.0000765-Sureau1">[29]</xref>; WELYSSA <xref ref-type="bibr" rid="pntd.0000765-Xu1">[26]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Xu2">[27]</xref>; RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skin biopsy (diameter of 4 mm, total volume of 20 mm<sup>3</sup>)</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">Skin biopsy collected at the nape of the neck, with hair follicles, using biopsy punch (Stiefel).</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">RT-hnPCR <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref></td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt102"><label>a</label><p>A minimum of three serially collected saliva samples and one skin biopsy from the nape of the neck are required for intra-vitam diagnosis of human rabies. This permits a sensitivity of 100% in patients presenting with encephalitic rabies (≥98% with skin biopsy alone and 100% with serial saliva samples). Skin biopsy samples can be collected irrespective of the time after the onset of symptoms. Analysis of additional samples may be advantageous. It includes RNA detection in serially collected urine and CSF samples, and rabies antibody measurement in serum and CSF. Rabies antibody detection is variable but increases with time after onset of symptoms (&gt;8 days) and can be informative with atypical or non-classical rabies. After collection, all samples have to be stored at −20°C/−80°C before shipment. Storage at +4°C or on ice should not exceed a few hours (&lt;6 h). All specimens should be shipped at −20°C or −80°C.</p></fn><fn id="nt103"><label/><p>FAT, fluorescent antibody test; RFFIT, rapid fluorescent focus inhibition test; RTCIT, rapid tissue culture infection test; RT-hnPCR, reverse transcription hemi-nested polymerase chain reaction; WELYSSA, ELISA dedicated to lyssavirus antigen detection.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd-0000765-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000765.t003</object-id><label>Table 3</label><caption>
<title>National Recommendations from the WHO-CC for Research and Training on Viral Zoonoses, Thailand, Concerning Biological Samples Collected for Diagnosis of Human Rabies.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pntd-0000765-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000765.t003" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="6" rowspan="1">Intra-Vitam Diagnosis of Human Rabies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Samples</td>
<td align="left" colspan="2" rowspan="1">Sensitivity Considering the Clinical Evolution of the Patient (in Days following the Onset of Symptoms)</td>
<td align="left" colspan="1" rowspan="1">Comments<xref ref-type="table-fn" rid="nt104">a</xref></td>
<td align="left" colspan="1" rowspan="1">Storage</td>
<td align="left" colspan="1" rowspan="1">Technique (Reference)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">0–8 Days</td>
<td align="left" colspan="1" rowspan="1">&gt;8 Days</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Saliva (1 mL or saliva swabs)</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">Collected once daily. Repeat testing if result is negative.Liquid saliva is preferable to saliva swabs.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>; TaqMan RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee3">[43]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Urine (at least 2 mL)</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Collected once daily. Repeat testing if result is negative.Fresh urine is preferable to stored samples.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>; TaqMan RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee3">[43]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Extracted hair (at least 20 follicles)</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Collected once daily. Repeat testing if result is negative.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>; TaqMan RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee3">[43]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CSF (1 mL)</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Average</td>
<td align="left" colspan="1" rowspan="1">Collected once daily. Repeat testing if result is negative.</td>
<td align="left" colspan="1" rowspan="1">−20°C/−80°C</td>
<td align="left" colspan="1" rowspan="1">NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>; TaqMan RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee3">[43]</xref></td>
</tr>
</tbody>
</table><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="5" rowspan="1">Post-Mortem Diagnosis of Human Rabies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Samples</td>
<td align="left" colspan="1" rowspan="1">Sensitivity</td>
<td align="left" colspan="1" rowspan="1">Comments</td>
<td align="left" colspan="1" rowspan="1">Storage</td>
<td align="left" colspan="1" rowspan="1">Technique (Reference)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Brain biopsy/autopsy</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">Brain biopsy collected via the orbital route with use of Tru-Cut biopsy needle (if full autopsy cannot be performed). In case of standard autopsy procedure, sample of brainstem region must be included.</td>
<td align="left" colspan="1" rowspan="1">+4°C/−20°C</td>
<td align="left" colspan="1" rowspan="1">FAT <xref ref-type="bibr" rid="pntd.0000765-Dean1">[28]</xref>; NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>; TaqMan RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee3">[43]</xref></td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt104"><label>a</label><p>Samples from all sources should be examined simultaneously due to the intermittent shedding of virus. If not possible, at least thrree of four less-invasive samples—saliva, extracted hair follicles, and urine—should be collected. Repeat testing if the first result is negative and test for other etiologic agent(s). RNA detection may be less sensitive on patient with paralytic rabies. Detection of rabies antibody is not sensitive in serum (approximately 25%) and CSF (none was found positive even 3 weeks after onset) in Asian dog related cases. Therefore, antibody detection-based assays are not recommended in this protocol. All specimens should be transported immediately (on ice) and if not possible, should be stored at +4°C for no longer than 24 h or at −20°C or −80°C (preferable) if storage time is longer.</p></fn><fn id="nt105"><label/><p>FAT, fluorescent antibody test; NASBA, nucleic acid sequence-based amplification; RT-PCR, reverse transcription polymerase chain reaction.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3">
<title>Preservation of Samples</title>
<p>It is also essential to mention the importance of the conditions required for the shipment and preservation of specimens, especially when molecular techniques will be used. The use of glycerol as a transport medium is convenient for brain biopsy samples <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>. However, the maintenance of a cold chain (+4°C or −20°C) remains essential when using samples for the intra-vitam diagnosis of rabies <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>. These preliminary steps still pose a challenge in most developing countries. A reliable system for transporting samples from hospitals to reference laboratories has to be organised. The use of commercial storage media for nucleic acid <xref ref-type="bibr" rid="pntd.0000765-Uhlenhaut1">[8]</xref>, RNA extraction reagents <xref ref-type="bibr" rid="pntd.0000765-Blow1">[9]</xref>, or filter paper technology <xref ref-type="bibr" rid="pntd.0000765-PicardMeyer1">[10]</xref> might be good alternatives.</p>
</sec><sec id="s4">
<title>Preparation of Samples</title>
<p>Different protocols have proved effective for the preparation of samples for viral RNA detection by nucleic acid extraction and reverse transcription (RT) <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>–<xref ref-type="bibr" rid="pntd.0000765-Trimarchi1">[14]</xref>. However, as emphasised in previous publications <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>, <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>, strict quality control measures must be followed to avoid false positive or negative results. This includes the use of appropriate controls for each step of the process (e.g., using endogeneous RNA as beta-actin or ribosomial 18S RNA, or other spiked and/or synthetic controls). This applies to RT, polymerase chain reaction (PCR), and other molecular techniques such as nucleic acid sequence-based amplification (NASBA) and loop-mediated isothermal amplification (LAMP) techniques. Positive results of viral RNA in samples should be confirmed by sequencing to avoid false positives, although it is recognised that sequencing capacity may not yet be available in most developing country settings. This also permits genotyping of viral strains, which is useful for epidemiological surveillance.</p>
</sec><sec id="s5">
<title>Choice of the Most Appropriate Molecular Techniques for Viral RNA Detection</title>
<p>Molecular techniques for the detection of rabies and rabies-related lyssaviruses usually use PCR methods targeting the viral nucleoprotein gene as indicated by Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>. However, another region of the lyssavirus viral genome, the polymerase gene, can also be used. This gene encompasses several nucleotide blocks (such as block III) that have been highly conserved during lyssavirus evolution <xref ref-type="bibr" rid="pntd.0000765-Bourhy1">[15]</xref>. A new RT, hemi-nested PCR (RT-hnPCR) protocol employing this region was developed and standardized in three laboratories, one in France and two in developing countries where rabies is still endemic (Cambodia and Madagascar) <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>. Using this RT-hnPCR, it was possible to diagnose human rabies (intra-vitam and post-mortem) using saliva, urine, and skin biopsy specimens collected from a large cohort of patients with suspected rabies (51 patients enrolled and 425 samples collected and analyzed). In this study, a sensitivity of more than 98% was obtained using single skin biopsy sample, irrespective of the time of collection (i.e., from 1 day after the onset of symptoms to just after death), and of 100% when at least three successive saliva samples per patient were analyzed. This study confirmed and complemented other results obtained by RT-PCR <xref ref-type="bibr" rid="pntd.0000765-Macedo1">[7]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Crepin1">[16]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Nagaraj1">[17]</xref> and by NASBA techniques <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref>, but not all were mentioned by Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>. All these results indicated that it is now possible to perform a reliable intra-vitam diagnosis of human rabies by collecting serial saliva samples <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Nagaraj1">[17]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref> or simply a skin biopsy from the nape of the neck, which shows a high sensitivity even when taken right at the time of admission <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Macedo1">[7]</xref>. RNA detection in skin biopsy tissues is more sensitive than in extracted hair follicles (98% versus 53%), although the latter is easier to perform <xref ref-type="bibr" rid="pntd.0000765-Hemachudha1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee1">[5]</xref>. These studies provide a clear demonstration of the feasibility of using molecular methods for human rabies diagnosis in developing countries (Brazil, Cambodia, India, Madagascar, Thailand, etc.). These techniques have also the potential to improve rabies surveillance, particularly in countries where the incidence is expected to be high, and the only evaluations have been made using mathematical models reliant on extrapolation <xref ref-type="bibr" rid="pntd.0000765-Knobel1">[1]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Ly1">[19]</xref>.</p>
</sec><sec id="s6">
<title>Rabies-Specific ELISA Techniques</title>
<p>ELISA techniques can be used for the detection of rabies antigens or anti-rabies IgG. These tests are rapid, cheap, easy to use, and safe because they do not require the use of infectious virus, making them suitable for use in developing countries.</p>
<sec id="s6a">
<title>Antigen Detection</title>
<p>Apart from the recently developed direct rapid immunohistochemical test (dRIT) <xref ref-type="bibr" rid="pntd.0000765-Lembo1">[20]</xref> and rapid immunodiagnostic test (RIDT) <xref ref-type="bibr" rid="pntd.0000765-Kang1">[21]</xref> for rabies antigens detection, a validated ELISA for the rapid post-mortem detection of antigen in brain samples is also available but was not mentioned by Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>. It has been evaluated under field conditions in different countries <xref ref-type="bibr" rid="pntd.0000765-Bourhy2">[22]</xref>–<xref ref-type="bibr" rid="pntd.0000765-Saxena1">[25]</xref> and its use is recommended by the WHO <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>. Another reliable, rapid, and transferable ELISA method named WELYSSA is designed to detect lyssaviruses belonging to all seven genotypes circulating in Europe, Africa, Asia, and Oceania <xref ref-type="bibr" rid="pntd.0000765-Xu1">[26]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Xu2">[27]</xref>. Performance of both of them have been compared to techniques of reference for rabies diagnosis, i.e., the gold standard fluorescent antibody test (FAT) <xref ref-type="bibr" rid="pntd.0000765-Dean1">[28]</xref> for rabies antigens detection and the rapid tissue culture infection test (RTCIT) <xref ref-type="bibr" rid="pntd.0000765-Sureau1">[29]</xref> for viral isolation (which should replace the mouse inoculation test <xref ref-type="bibr" rid="pntd.0000765-Webster1">[30]</xref>, according to WHO recommendations). Results demonstrated a high concordance in terms of sensitivity and specificity <xref ref-type="bibr" rid="pntd.0000765-Bourhy2">[22]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Xu1">[26]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Xu2">[27]</xref>.</p>
</sec><sec id="s6b">
<title>Antibody Detection</title>
<p>An ELISA for antibody detection is also recommended by the WHO for testing serum or CSF from patients with rabies encephalitis, but mainly for assessment of the immune status of vaccinated patients <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref> especially when the reference methods, the rapid fluorescent focus inhibition test (RFFIT) <xref ref-type="bibr" rid="pntd.0000765-Smith1">[31]</xref> or fluorescent antibody virus neutralization test (FAVN) <xref ref-type="bibr" rid="pntd.0000765-Cliquet1">[32]</xref>, cannot be performed, as is usually the case in developing countries. Although not mentioned in <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>, several previously published studies have compared the sensitivity of such methods to standardized reference methods <xref ref-type="bibr" rid="pntd.0000765-Feyssaguet1">[33]</xref>–<xref ref-type="bibr" rid="pntd.0000765-Welch1">[35]</xref>. In particular, a second generation ELISA test, the Platelia Rabies II (Bio-Rad), has been favourably evaluated in a multicentric study <xref ref-type="bibr" rid="pntd.0000765-Feyssaguet1">[33]</xref> and it is used in several developing countries (Vietnam, Cambodia, Senegal, Morocco, Madagascar) <xref ref-type="bibr" rid="pntd.0000765-Wertheim1">[36]</xref>. This shows that these methods can be easily transferred and used in laboratories that do not have the facilities for tissue culture or viral production techniques.</p>
</sec></sec><sec id="s7">
<title>Conclusion</title>
<p>As underlined by Fooks et al. <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>, the development of new molecular tools for the detection of rabies virus, such as microarrays for lyssavirus detection <xref ref-type="bibr" rid="pntd.0000765-Berthet1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Gurrala1">[38]</xref> or antibody titrations using lentiviral pseudotypes <xref ref-type="bibr" rid="pntd.0000765-Wright1">[39]</xref> are aimed at improving rabies surveillance and control activities. However, their applicability in laboratories in most rabies-endemic countries is debatable. On the other hand, validated, robust techniques already exist and should be transferred to these regions, monitored by quality control and regular interlaboratory evaluations. These include methods for viral isolation using RTCIT <xref ref-type="bibr" rid="pntd.0000765-Sureau1">[29]</xref>, and for antigen detection with ELISA tools <xref ref-type="bibr" rid="pntd.0000765-Xu1">[26]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Xu2">[27]</xref>, dRIT <xref ref-type="bibr" rid="pntd.0000765-Lembo1">[20]</xref>, RIDT <xref ref-type="bibr" rid="pntd.0000765-Kang1">[21]</xref>, and the gold standard FAT technique <xref ref-type="bibr" rid="pntd.0000765-Dean1">[28]</xref>. International programmes of networking, collaboration, training, and proficiency testing of these techniques should be further encouraged <xref ref-type="bibr" rid="pntd.0000765-Cliquet2">[40]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Dodet1">[41]</xref>. Molecular diagnostic tools such as RT-PCR, real-time PCR, or other techniques such as NASBA <xref ref-type="bibr" rid="pntd.0000765-Hemachudha2">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000765-Wacharapluesadee2">[18]</xref> or LAMP <xref ref-type="bibr" rid="pntd.0000765-Boldbaatar1">[42]</xref> should be made available more widely for the intra-vitam and post-mortem diagnosis of human rabies in rabies-endemic countries. An example of successful sharing and transferring of these molecular techniques between laboratories in both developed and developing countries has already demonstrated its feasibility <xref ref-type="bibr" rid="pntd.0000765-Dacheux1">[3]</xref>. The choice of the most relevant biological samples to collect and analyze remains essential and has to be clearly defined. We therefore provide recommendations from two reference laboratories concerning biological samples collection for human rabies diagnosis (<xref ref-type="table" rid="pntd-0000765-t002">Tables 2</xref> and <xref ref-type="table" rid="pntd-0000765-t003">3</xref>). In particular, analysis of three serially collected saliva samples and one skin biopsy taken from the nape of the neck offer the highest level of sensitivity. Analysis of other samples may improve sensitivity (<xref ref-type="table" rid="pntd-0000765-t002">Tables 2</xref> and <xref ref-type="table" rid="pntd-0000765-t003">3</xref>). Stringent quality control measures are required to avoid false positive results due to the high sensitivity of PCR and NASBA techniques <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>. As underlined by previous publications <xref ref-type="bibr" rid="pntd.0000765-Fooks1">[2]</xref>, <xref ref-type="bibr" rid="pntd.0000765-NadinDavis2">[13]</xref>, another major limitation is the lack of international standards for sensitivity determination of these techniques, making comparisons difficult. Until these standards are developed, we strongly urge that only molecular techniques that have been evaluated in local laboratories in rabies-enzootic countries are used on appropriate samples for human rabies diagnosis <xref ref-type="bibr" rid="pntd.0000765-World1">[6]</xref>. Proposing a list of technological parameters characterizing these methods independently from the description of biological samples and laboratory environments for which they are designed could result in a misrepresentation of the future development of human rabies laboratory diagnosis in the developing world.</p>
</sec></body>
<back>
<ack>
<p>We are grateful to Mary J. Warrell for helpful discussions and critical review of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pntd.0000765-Knobel1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Knobel</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Cleaveland</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Coleman</surname><given-names>PG</given-names></name>
<name name-style="western"><surname>Fèvre</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Meltzer</surname><given-names>MI</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Re-evaluating the burden of rabies in Africa and Asia.</article-title>             <source>Bull World Health Organ</source>             <volume>83</volume>             <fpage>360</fpage>             <lpage>368</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Fooks1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fooks</surname><given-names>AR</given-names></name>
<name name-style="western"><surname>Johnson</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Freuling</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Wakeley</surname><given-names>PR</given-names></name>
<name name-style="western"><surname>Banyard</surname><given-names>AC</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e530</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000530" xlink:type="simple">10.1371/journal.pntd.0000530</ext-link></comment>          </element-citation></ref>
<ref id="pntd.0000765-Dacheux1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dacheux</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Reynes</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Buchy</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Sivuth</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Diop</surname><given-names>BM</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>A reliable diagnosis of human rabies based on analysis of skin biopsy specimens.</article-title>             <source>Clin Infect Dis</source>             <volume>47</volume>             <fpage>1410</fpage>             <lpage>1417</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Hemachudha1"><label>4</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hemachudha</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Wilde</surname><given-names>H</given-names></name>
</person-group>             <year>2009</year>             <article-title>Rabies.</article-title>             <comment>In: PIER [online database]. Philadelphia: American college of Physicians. Available: <ext-link ext-link-type="uri" xlink:href="http://pier.acponline.org/physicians/diseases/d267/d267.html" xlink:type="simple">http://pier.acponline.org/physicians/diseases/d267/d267.html</ext-link>). Accessed</comment>          </element-citation></ref>
<ref id="pntd.0000765-Wacharapluesadee1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wacharapluesadee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hemachudha</surname><given-names>T</given-names></name>
</person-group>             <year>2010</year>             <article-title>Ante- and post-mortem diagnosis of rabies using nucleic acid-amplification tests.</article-title>             <source>Expert Rev Mol Diagn</source>             <volume>10</volume>             <fpage>207</fpage>             <lpage>218</lpage>          </element-citation></ref>
<ref id="pntd.0000765-World1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">World Health Organization</collab>             <year>2005</year>             <article-title>WHO Expert Consultation on rabies.</article-title>             <source>World Health Organ Tech Rep Ser</source>             <volume>931</volume>             <fpage>1</fpage>             <lpage>88</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Macedo1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Macedo</surname><given-names>CI</given-names></name>
<name name-style="western"><surname>Carnieli</surname><given-names>P</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Brandao</surname><given-names>PE</given-names></name>
<name name-style="western"><surname>Travassos da Rosa</surname><given-names>ES</given-names></name>
<name name-style="western"><surname>Oliveira Rde</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Diagnosis of human rabies cases by polymerase chain reaction of neck-skin samples.</article-title>             <source>Braz J Infect Dis</source>             <volume>10</volume>             <fpage>341</fpage>             <lpage>345</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Uhlenhaut1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Uhlenhaut</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kracht</surname><given-names>M</given-names></name>
</person-group>             <year>2005</year>             <article-title>Viral infectivity is maintained by an RNA protection buffer.</article-title>             <source>J Virol Methods</source>             <volume>128</volume>             <fpage>189</fpage>             <lpage>191</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Blow1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Blow</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Mores</surname><given-names>CN</given-names></name>
<name name-style="western"><surname>Dyer</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Dohm</surname><given-names>DJ</given-names></name>
</person-group>             <year>2008</year>             <article-title>Viral nucleic acid stabilization by RNA extraction reagent.</article-title>             <source>J Virol Methods</source>             <volume>150</volume>             <fpage>41</fpage>             <lpage>44</lpage>          </element-citation></ref>
<ref id="pntd.0000765-PicardMeyer1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Picard-Meyer</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Barrat</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Cliquet</surname><given-names>F</given-names></name>
</person-group>             <year>2007</year>             <article-title>Use of filter paper (FTA) technology for sampling, recovery and molecular characterisation of rabies viruses.</article-title>             <source>J Virol Methods</source>             <volume>140</volume>             <fpage>174</fpage>             <lpage>182</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Hemachudha2"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hemachudha</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Wacharapluesadee</surname><given-names>S</given-names></name>
</person-group>             <year>2004</year>             <article-title>Antemortem diagnosis of human rabies.</article-title>             <source>Clin Infect Dis</source>             <volume>39</volume>             <fpage>1085</fpage>             <lpage>1086</lpage>          </element-citation></ref>
<ref id="pntd.0000765-NadinDavis1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nadin-Davis</surname><given-names>SA</given-names></name>
</person-group>             <year>1998</year>             <article-title>Polymerase chain reaction protocols for rabies virus discrimination.</article-title>             <source>J Virol Methods</source>             <volume>75</volume>             <fpage>1</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pntd.0000765-NadinDavis2"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nadin-Davis</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Sheen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wandeler</surname><given-names>AI</given-names></name>
</person-group>             <year>2009</year>             <article-title>Development of real-time reverse transcriptase polymerase chain reaction methods for human rabies diagnosis.</article-title>             <source>J Med Virol</source>             <volume>81</volume>             <fpage>1484</fpage>             <lpage>1497</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Trimarchi1"><label>14</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Trimarchi</surname><given-names>CV</given-names></name>
<name name-style="western"><surname>Nadin-Davis</surname><given-names>SA</given-names></name>
</person-group>             <year>2007</year>             <article-title>Diagnostic evaluation.</article-title>             <person-group person-group-type="editor">
<name name-style="western"><surname>Jackson</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Wunner</surname><given-names>WH</given-names></name>
</person-group>             <source>Rabies. 2nd edition</source>             <publisher-loc>New York</publisher-loc>             <publisher-name>Academic Press</publisher-name>             <fpage>411</fpage>             <lpage>469</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Bourhy1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bourhy</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Cowley</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Larrous</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Holmes</surname><given-names>EC</given-names></name>
<name name-style="western"><surname>Walker</surname><given-names>PJ</given-names></name>
</person-group>             <year>2005</year>             <article-title>Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene.</article-title>             <source>J Gen Virol</source>             <volume>86</volume>             <fpage>2849</fpage>             <lpage>2858</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Crepin1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Crepin</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Audry</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Rotivel</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Gacoin</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Caroff</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>1998</year>             <article-title>Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid.</article-title>             <source>J Clin Microbiol</source>             <volume>36</volume>             <fpage>1117</fpage>             <lpage>1121</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Nagaraj1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nagaraj</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Vasanth</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Desai</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kamat</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Madhusudana</surname><given-names>SN</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Ante mortem diagnosis of human rabies using saliva samples: comparison of real time and conventional RT-PCR techniques.</article-title>             <source>J Clin Virol</source>             <volume>36</volume>             <fpage>17</fpage>             <lpage>23</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Wacharapluesadee2"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wacharapluesadee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hemachudha</surname><given-names>T</given-names></name>
</person-group>             <year>2001</year>             <article-title>Nucleic-acid sequence based amplification in the rapid diagnosis of rabies.</article-title>             <source>Lancet</source>             <volume>358</volume>             <fpage>892</fpage>             <lpage>893</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Ly1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ly</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Buchy</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Heng</surname><given-names>NY</given-names></name>
<name name-style="western"><surname>Ong</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Chhor</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Rabies situation in Cambodia.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e511</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000511" xlink:type="simple">10.1371/journal.pntd.0000511</ext-link></comment>          </element-citation></ref>
<ref id="pntd.0000765-Lembo1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lembo</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Niezgoda</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Velasco-Villa</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Cleaveland</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ernest</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis.</article-title>             <source>Emerg Infect Dis</source>             <volume>12</volume>             <fpage>310</fpage>             <lpage>313</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Kang1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kang</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Oh</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Park</surname><given-names>BK</given-names></name>
<name name-style="western"><surname>Park</surname><given-names>Y</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Evaluation of a rapid immunodiagnostic test kit for rabies virus.</article-title>             <source>J Virol Methods</source>             <volume>145</volume>             <fpage>30</fpage>             <lpage>36</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Bourhy2"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bourhy</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Rollin</surname><given-names>PE</given-names></name>
<name name-style="western"><surname>Vincent</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sureau</surname><given-names>P</given-names></name>
</person-group>             <year>1989</year>             <article-title>Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies.</article-title>             <source>J Clin Microbiol</source>             <volume>27</volume>             <fpage>519</fpage>             <lpage>523</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Jayakumar1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jayakumar</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Ramadass</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Raghavan</surname><given-names>N</given-names></name>
</person-group>             <year>1989</year>             <article-title>Comparison of enzyme immunodiagnosis with immunofluorescence for rapid diagnosis of rabies in dogs.</article-title>             <source>Zentralbl Bakteriol</source>             <volume>271</volume>             <fpage>501</fpage>             <lpage>503</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Morvan1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Morvan</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Mouden</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Coulanges</surname><given-names>P</given-names></name>
</person-group>             <year>1990</year>             <article-title>[Rapid diagnosis of rabies by the ELISA method. Its application in Madagascar: advantages and disadvantages].</article-title>             <source>Arch Inst Pasteur Madagascar</source>             <volume>57</volume>             <fpage>193</fpage>             <lpage>203</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Saxena1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Saxena</surname><given-names>SN</given-names></name>
<name name-style="western"><surname>Madhusudana</surname><given-names>SN</given-names></name>
<name name-style="western"><surname>Tripathi</surname><given-names>KK</given-names></name>
<name name-style="western"><surname>Gupta</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Ahuja</surname><given-names>S</given-names></name>
</person-group>             <year>1989</year>             <article-title>Evaluation of the new rapid rabies immunodiagnosis technique.</article-title>             <source>Indian J Med Res</source>             <volume>89</volume>             <fpage>445</fpage>             <lpage>448</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Xu1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Xu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Weber</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Xue</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Audry</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies.</article-title>             <source>Biologicals</source>             <volume>35</volume>             <fpage>297</fpage>             <lpage>302</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Xu2"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Xu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Weber</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Xue</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Audry</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>WELYSSA: a simple tool using mouse monoclonal antibodies for the detection of lyssavirus nucleocapsid in rabies suspected specimens.</article-title>             <source>Dev Biol (Basel)</source>             <volume>131</volume>             <fpage>555</fpage>             <lpage>561</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Dean1"><label>28</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dean</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Abelseth</surname><given-names>MK</given-names></name>
</person-group>             <year>1973</year>             <article-title>The fluorescent antibody test.</article-title>             <person-group person-group-type="editor">
<name name-style="western"><surname>Kaplan</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Kowprowski</surname><given-names>H</given-names></name>
</person-group>             <source>Laboratory techniques in rabies. 3rd edition</source>             <publisher-loc>Geneva</publisher-loc>             <publisher-name>World Health Organization</publisher-name>             <fpage>73</fpage>             <lpage>84</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Sureau1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sureau</surname><given-names>P</given-names></name>
</person-group>             <year>1986</year>             <article-title>Les techniques rapides de diagnostic de laboratoire de la rage.</article-title>             <source>Arch Inst Pasteur Tunis</source>             <volume>63</volume>             <fpage>183</fpage>             <lpage>197</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Webster1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Webster</surname><given-names>LT</given-names></name>
<name name-style="western"><surname>Dawson</surname><given-names>JR</given-names></name>
</person-group>             <year>1935</year>             <article-title>Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test.</article-title>             <source>Proc Soc Exp Biol Med</source>             <volume>32</volume>             <fpage>570</fpage>             <lpage>573</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Smith1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Smith</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Yager</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Baer</surname><given-names>GM</given-names></name>
</person-group>             <year>1973</year>             <article-title>A rapid reproducible test for determining rabies neutralizing antibody.</article-title>             <source>Bull World Health Organ</source>             <volume>48</volume>             <fpage>535</fpage>             <lpage>541</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Cliquet1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cliquet</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Aubert</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Sagne</surname><given-names>L</given-names></name>
</person-group>             <year>1998</year>             <article-title>Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody.</article-title>             <source>J Immunol Methods</source>             <volume>212</volume>             <fpage>79</fpage>             <lpage>87</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Feyssaguet1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Feyssaguet</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Dacheux</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Audry</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Compoint</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Morize</surname><given-names>JL</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.</article-title>             <source>Vaccine</source>             <volume>25</volume>             <fpage>2244</fpage>             <lpage>2251</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Muhamuda1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Muhamuda</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Madhusudana</surname><given-names>SN</given-names></name>
<name name-style="western"><surname>Ravi</surname><given-names>V</given-names></name>
</person-group>             <year>2007</year>             <article-title>Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.</article-title>             <source>Int J Infect Dis</source>             <volume>11</volume>             <fpage>441</fpage>             <lpage>445</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Welch1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Welch</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Anderson</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Litwin</surname><given-names>CM</given-names></name>
</person-group>             <year>2009</year>             <article-title>An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.</article-title>             <source>J Med Microbiol</source>             <volume>58</volume>             <fpage>806</fpage>             <lpage>810</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Wertheim1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wertheim</surname><given-names>HF</given-names></name>
<name name-style="western"><surname>Nguyen</surname><given-names>TQ</given-names></name>
<name name-style="western"><surname>Nguyen</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>de Jong</surname><given-names>MD</given-names></name>
<name name-style="western"><surname>Taylor</surname><given-names>WR</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Furious rabies after an atypical exposure.</article-title>             <source>PLoS Med</source>             <volume>6</volume>             <fpage>e44</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.1000044" xlink:type="simple">10.1371/journal.pmed.1000044</ext-link></comment>          </element-citation></ref>
<ref id="pntd.0000765-Berthet1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Berthet</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Dickinson</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Filliol</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Reinhardt</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Batejat</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Massively parallel pathogen identification using high-density microarrays.</article-title>             <source>Microb Biotechnol</source>             <volume>1</volume>             <fpage>79</fpage>             <lpage>86</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Gurrala1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gurrala</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Dastjerdi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Johnson</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Nunez-Garcia</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Grierson</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Development of a DNA microarray for simultaneous detection and genotyping of lyssaviruses.</article-title>             <source>Virus Res</source>             <volume>144</volume>             <fpage>202</fpage>             <lpage>208</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Wright1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wright</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Temperton</surname><given-names>NJ</given-names></name>
<name name-style="western"><surname>Marston</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>McElhinney</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Fooks</surname><given-names>AR</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.</article-title>             <source>J Gen Virol</source>             <volume>89</volume>             <fpage>2204</fpage>             <lpage>2213</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Cliquet2"><label>40</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cliquet</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Biarnais</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Schereffer</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Barrat</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Picard-Meyer</surname><given-names>E</given-names></name>
</person-group>             <year>2008</year>             <article-title>Rabies proficiency test for rabies diagnosis using the direct fluorescent antibody test.</article-title>             <comment>Meeting Abstract. XIX International conference on rabies in the Americas (RITA). Atlanta, GA, USA</comment>          </element-citation></ref>
<ref id="pntd.0000765-Dodet1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dodet</surname><given-names>B</given-names></name>
</person-group>             <year>2009</year>             <article-title>The fight against rabies in Africa: From recognition to action.</article-title>             <source>Vaccine</source>             <volume>27</volume>             <fpage>5027</fpage>             <lpage>5032</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Boldbaatar1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Boldbaatar</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Inoue</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sugiura</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Noguchi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Orbina</surname><given-names>JR</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Rapid detection of rabies virus by reverse transcription loop-mediated isothermal amplification.</article-title>             <source>Jpn J Infect Dis</source>             <volume>62</volume>             <fpage>187</fpage>             <lpage>191</lpage>          </element-citation></ref>
<ref id="pntd.0000765-Wacharapluesadee3"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wacharapluesadee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sutipanya</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Damrongwatanapokin</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Phumesin</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Chamnanpood</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Development of a TaqMan real-time RT-PCR assay for the detection of rabies virus.</article-title>             <source>J Virol Methods</source>             <volume>151</volume>             <fpage>317</fpage>             <lpage>320</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>